
cent, from the previous session, as of 2 p.m. After opening at 760,000 won, the stock failed to rebound and continued to fluctuate in a weak range, even briefly touching the day's low of 753,000 won.T
ated after a recently announced US licensing deal for an oral insulin and weight-loss pill fell short of market expectations, as investors questioned the terms of the agreement. Sam Chun Dang Pharm al
当前文章:http://www.23011111.com/ayb/l4hh.pptx
发布时间:00:06:35